in silico Clinical Trials
“The use of individualised computer simulation in the development or regulatory evaluation of a medicinal product or medical device/medical intervention.“
Welcome to the Avicenna website!
The Avicenna project is now concluded and the website is closed. For further information please go to the Avicenna Alliance tab.
We are a consortium funded by the European Commission, tasked with three objectives:
2. Establishing a partnership between the biomedical industry and European research organisations, with the aim of developing the technology, methods, protocols and standards required for in silico clinical trials to become a reality.
3. Identifying technologies, determining early examples of in silico clinical trails.
Over the length of the project until mid-2015 we are inviting experts and stakeholders from various relevant domains to help us by participating in discussions at a series of events. Avicenna’s ambition is to bring together representatives from the biomedical industries and regulatory agencies, researchers, and developers of computational technologies, in order to develop a pre-competitive reflection of what in silico methods can offer, and where there are scientific, technological, or regulatory barriers that, if overcome would make the development of innovative biomedical products easier, faster and cheaper.
Avicenna – A Strategy for in silico Clinical Trials is a Coordination and Support Action funded by the European Commission as part of the Seventh Framework Program for Research and Technological Development (FP7), under the Information Communication Technologies Programme (Contract Number 611819).